STOCK DIVIDEND AND STOCK SPLIT
The most common method for companies to distribute wealth among shareholders is to pay dividends in the form of cash or stock. When a company has a low level of liquid cash on hand, stock dividends are typically issued in lieu of cash dividends. It is the board of directors that decides whether a dividend should be declared and in what form it should be distributed. Dividend yield is also a financial ratio that shows how much a company pays out in dividends on its shares each year, which is something investors look for in a stock.
Dividend Rate
Trailing Annual Dividend Rate
$0.60
Forward Annual Dividend Rate
$1.53
Yield
Trailing Annual Dividend Yield
1%
Forward Annual Dividend Yield
3.9%
Dividend Date
Dividend Date
Apr 10, 2025
Ex-dividend Date
Feb 21, 2025
4.87 %
94.91
Dividend History
Stock Split History
Frequently Asked Questions
Is GSK plc (GSK) a dividend paying company?
In a company, dividends are a portion of profits paid out to shareholders - investors getting a little bit back on their investment. In particular, dividends benefit investors, especially income-seeking investors, because they provide mutual benefits both to companies and investors. Dividends are a strong indicator for a company's ability to produce profits consistently and reflect favorably on its management. GSK plc is also among the companies that regularly pay dividends.
What is GSK's dividend yield?
Many factors affect dividend yields, including global market conditions, interest rates, and the financial status of an individual company.However, the average dividend yield for a good company is between 2% and 6%. GSK's annual dividend yield for the trailing 12 months is 1.00.
When did GSK last pay a dividend?
GSK last paid dividends on 2025-04-10, with the ex-dividend date being 2025-02-21.
When was the last time GSK stock split?
GSK stock split took place on 2022-07-22.
How did GSK's stock split work?
Its last split took place on Jul 22, 2022, when GSK plc went through a 0.8:1 split leaving the shareholder with 0.8 share(s) who previously owned 1 GSK share(s).